Diabet- Diabetic neuropathy.. Type 2 diabetes mellitus with diabetic neuropathy, unspecified.
Conditions
Interventions
Intervention 1: Intervention group: Patients with diabetic neuropathy will be treated with Gabapentin 100 mg every night and clonidine 0.2 mg every morning. Intervention 2: Control group: Patients wit
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes who have symptoms associated with peripheral neuropathy. No chronic illness (cardiovascular, renal and thyroid disorders), severe neurology or psychiatry. Do not be pregnant or breastfeeding. Not taking medications that are effective in exacerbating or alleviating neuropathy. Age between 30 and 60 years old.
Exclusion criteria
Exclusion criteria: Having severe sensitivity to Clonidine Having neuropathy with proven reasons except Diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of neuropathy in this study based on the Michigan Questionnaire, pain based on the McGill Pain Questionnaire. Timepoint: Before the start of the study and 14, 28, 56 days later. Method of measurement: The Michigan Questionnaire, the McGill Questionnaire, and the researcher-designed questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoraya Bagheri
Yasouj University of Medical Sciences
Outcome results
None listed